The Effect of Workplace Interventions on the Treatment of Low-back Pain

Workplace Interventions Supporting Employees to Continue at Work: Participatory Actions Organized by OH Physiotherapist

The study evaluates the effect of workplace interventions on work ability promotion among workers with back problems. The half of participant will receive Information, advice and guidance for back problems in addition to participatory workplace actions organized by Occupational Health Physiotherapist. The other half will receive only Information, advice and guidance without workplace intervention.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Musculoskeletal symptoms, especially back pain, account for the majority of days lost.

In order to enhance the health and working careers of people with MSD, it is important that work can be arranged in such a way that they can remain in work life despite MSD.In the field of work ability promotion, various stakeholders; the worker, employer, professionals in occupational health services (OHS) interact to optimize actions and practices to prevent absences from work and promote remaining at work. This study aims to investigate participatory working practices and modles of co-operation among OHS and workplaces.

Study Type

Interventional

Enrollment (Actual)

107

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Helsinki, Finland, 00032
        • Finnish Institute of Occupational Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Back pain for at least two weeks or frequently occuring periods within the past 12 months

Exclusion Criteria:

  • Back problems with forcoming surcical operation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Workplace intervention group
Workers with back problems receive both information/advice and participatory workplace intervention organized by Occupational Health Physioterapist.
The study contains normal services of occupational health. Both intervention groups are based on voluntary will, and the normal care and services are guaranteed. In the intervention group new working method which improve co-operation between occupational health services and workplaces.
No Intervention: Information and advice group
Workers with back problems receive only information / advice by Occupational Health Physiotherapist, not the workplace intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
work ability
Time Frame: through study completion, up to 12 months
The present self estimated work ability versus the life time best (0-10)
through study completion, up to 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
intensity of pack pain
Time Frame: through study completion, up to 12 months
The present self estimated back pain, no pain - the worst pain
through study completion, up to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Erja Sormunen, PhD, Finnish Institute of Occupational Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2017

Primary Completion (Actual)

April 30, 2019

Study Completion (Actual)

August 30, 2019

Study Registration Dates

First Submitted

November 6, 2017

First Submitted That Met QC Criteria

March 27, 2018

First Posted (Actual)

March 29, 2018

Study Record Updates

Last Update Posted (Actual)

April 8, 2021

Last Update Submitted That Met QC Criteria

April 5, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ESormunen

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

All the collected data and study results are analyzed anonymous and are kept under the control of the Project group. All the personal data and information of the participants are kept under the control of the Project researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Back Pain

Clinical Trials on Workplace intervention

Subscribe